NEBRASKA ORTHOPAEDIC HOSPITAL LLC — History
CCN 280129 | 3-year financial timeline | COVID resilience: 82/100
🛡️ Public data only — no PHI permitted on this instance.
$112M
Latest Revenue (FY2022)
+15.2%
Revenue CAGR (3yr)
22.5%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $84M | $99M | $112M | +13.3% | +15.2% |
| Operating Expenses | $73M | $78M | $87M | +12.0% | +8.9% |
| Operating Margin | 13.3% | 21.5% | 22.5% | +4.3% | +30.1% |
| Net Income | $11M | $21M | $25M | +18.2% | +49.9% |
| Licensed Beds | 24 | 24 | 24 | +0.0% | +0.0% |
| Total Patient Days | 1,829 | 743 | 522 | -29.7% | -46.6% |
| Medicare Day % | 42% | 44% | 44% | -1.2% | +2.1% |
| Medicaid Day % | 1% | 1% | 4% | +158.8% | +78.5% |
COVID Impact & Recovery
Resilience Score: 82/100 — Resilient — strong COVID recovery
Revenue recovery from FY2020 to FY2022: +32.7% ($84M → $112M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▶ Stable
Medicare Mix▼ Declining
vs State Average ()
Revenue Growth
+15.2%
This Hospital
+7.6%
State Avg
Latest Margin
22.5%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $126M | 27.1% |
| FY2024 (proj) | $140M | 31.7% |
| FY2025 (proj) | $154M | 36.3% |